Global NSAIDs for Dysmenorrhea Market Research Report 2023

NSAIDs for Dysmenorrhea Market

Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NSAIDs for Dysmenorrhea market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global NSAIDs for Dysmenorrhea market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of NSAIDs for Dysmenorrhea Market Report

1.1 Product Overview and Scope of NSAIDs for Dysmenorrhea

1.2 NSAIDs for Dysmenorrhea Segment by Type

1.2.1 Global NSAIDs for Dysmenorrhea Market Value Comparison by Type (2023-2029)

1.2.2 Ibuprofen

1.2.3 Celecoxib

1.2.4 Ketoprofen

1.2.5 Others

1.3 NSAIDs for Dysmenorrhea Segment by Application

1.3.1 Global NSAIDs for Dysmenorrhea Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Pharmacy

1.3.5 Other

1.4 Global NSAIDs for Dysmenorrhea Market Size Estimates and Forecasts

1.4.1 Global NSAIDs for Dysmenorrhea Revenue 2018-2029

1.4.2 Global NSAIDs for Dysmenorrhea Sales 2018-2029

1.4.3 Global NSAIDs for Dysmenorrhea Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global NSAIDs for Dysmenorrhea Sales Market Share by Manufacturers (2018-2023)

2.2 Global NSAIDs for Dysmenorrhea Revenue Market Share by Manufacturers (2018-2023)

2.3 Global NSAIDs for Dysmenorrhea Average Price by Manufacturers (2018-2023)

2.4 Global NSAIDs for Dysmenorrhea Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of NSAIDs for Dysmenorrhea, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of NSAIDs for Dysmenorrhea, Product Type & Application

2.7 NSAIDs for Dysmenorrhea Market Competitive Situation and Trends

2.7.1 NSAIDs for Dysmenorrhea Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest NSAIDs for Dysmenorrhea Players Market Share by Revenue

2.7.3 Global NSAIDs for Dysmenorrhea Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global NSAIDs for Dysmenorrhea Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global NSAIDs for Dysmenorrhea Global NSAIDs for Dysmenorrhea Sales by Region: 2018-2029

3.2.1 Global NSAIDs for Dysmenorrhea Sales by Region: 2018-2023

3.2.2 Global NSAIDs for Dysmenorrhea Sales by Region: 2024-2029

3.3 Global NSAIDs for Dysmenorrhea Global NSAIDs for Dysmenorrhea Revenue by Region: 2018-2029

3.3.1 Global NSAIDs for Dysmenorrhea Revenue by Region: 2018-2023

3.3.2 Global NSAIDs for Dysmenorrhea Revenue by Region: 2024-2029

3.4 North America NSAIDs for Dysmenorrhea Market Facts & Figures by Country

3.4.1 North America NSAIDs for Dysmenorrhea Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America NSAIDs for Dysmenorrhea Sales by Country (2018-2029)

3.4.3 North America NSAIDs for Dysmenorrhea Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe NSAIDs for Dysmenorrhea Market Facts & Figures by Country

3.5.1 Europe NSAIDs for Dysmenorrhea Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe NSAIDs for Dysmenorrhea Sales by Country (2018-2029)

3.5.3 Europe NSAIDs for Dysmenorrhea Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific NSAIDs for Dysmenorrhea Market Facts & Figures by Country

3.6.1 Asia Pacific NSAIDs for Dysmenorrhea Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific NSAIDs for Dysmenorrhea Sales by Country (2018-2029)

3.6.3 Asia Pacific NSAIDs for Dysmenorrhea Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America NSAIDs for Dysmenorrhea Market Facts & Figures by Country

3.7.1 Latin America NSAIDs for Dysmenorrhea Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America NSAIDs for Dysmenorrhea Sales by Country (2018-2029)

3.7.3 Latin America NSAIDs for Dysmenorrhea Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa NSAIDs for Dysmenorrhea Market Facts & Figures by Country

3.8.1 Middle East and Africa NSAIDs for Dysmenorrhea Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa NSAIDs for Dysmenorrhea Sales by Country (2018-2029)

3.8.3 Middle East and Africa NSAIDs for Dysmenorrhea Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global NSAIDs for Dysmenorrhea Sales by Type (2018-2029)

4.1.1 Global NSAIDs for Dysmenorrhea Sales by Type (2018-2023)

4.1.2 Global NSAIDs for Dysmenorrhea Sales by Type (2024-2029)

4.1.3 Global NSAIDs for Dysmenorrhea Sales Market Share by Type (2018-2029)

4.2 Global NSAIDs for Dysmenorrhea Revenue by Type (2018-2029)

4.2.1 Global NSAIDs for Dysmenorrhea Revenue by Type (2018-2023)

4.2.2 Global NSAIDs for Dysmenorrhea Revenue by Type (2024-2029)

4.2.3 Global NSAIDs for Dysmenorrhea Revenue Market Share by Type (2018-2029)

4.3 Global NSAIDs for Dysmenorrhea Price by Type (2018-2029)

5.1 Global NSAIDs for Dysmenorrhea Sales by Application (2018-2029)

5.1.1 Global NSAIDs for Dysmenorrhea Sales by Application (2018-2023)

5.1.2 Global NSAIDs for Dysmenorrhea Sales by Application (2024-2029)

5.1.3 Global NSAIDs for Dysmenorrhea Sales Market Share by Application (2018-2029)

5.2 Global NSAIDs for Dysmenorrhea Revenue by Application (2018-2029)

5.2.1 Global NSAIDs for Dysmenorrhea Revenue by Application (2018-2023)

5.2.2 Global NSAIDs for Dysmenorrhea Revenue by Application (2024-2029)

5.2.3 Global NSAIDs for Dysmenorrhea Revenue Market Share by Application (2018-2029)

5.3 Global NSAIDs for Dysmenorrhea Price by Application (2018-2029)

6.1 IOLCP

6.1.1 IOLCP Corporation Information

6.1.2 IOLCP Description and Business Overview

6.1.3 IOLCP NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.1.4 IOLCP NSAIDs for Dysmenorrhea Product Portfolio

6.1.5 IOLCP Recent Developments/Updates

6.2 Granules Biocause

6.2.1 Granules Biocause Corporation Information

6.2.2 Granules Biocause Description and Business Overview

6.2.3 Granules Biocause NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Granules Biocause NSAIDs for Dysmenorrhea Product Portfolio

6.2.5 Granules Biocause Recent Developments/Updates

6.3 Strides Shasun

6.3.1 Strides Shasun Corporation Information

6.3.2 Strides Shasun Description and Business Overview

6.3.3 Strides Shasun NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Strides Shasun NSAIDs for Dysmenorrhea Product Portfolio

6.3.5 Strides Shasun Recent Developments/Updates

6.4 BASF

6.4.1 BASF Corporation Information

6.4.2 BASF Description and Business Overview

6.4.3 BASF NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.4.4 BASF NSAIDs for Dysmenorrhea Product Portfolio

6.4.5 BASF Recent Developments/Updates

6.5 SI Group

6.5.1 SI Group Corporation Information

6.5.2 SI Group Description and Business Overview

6.5.3 SI Group NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.5.4 SI Group NSAIDs for Dysmenorrhea Product Portfolio

6.5.5 SI Group Recent Developments/Updates

6.6 Hisoar

6.6.1 Hisoar Corporation Information

6.6.2 Hisoar Description and Business Overview

6.6.3 Hisoar NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Hisoar NSAIDs for Dysmenorrhea Product Portfolio

6.6.5 Hisoar Recent Developments/Updates

6.7 Pfizer Inc

6.6.1 Pfizer Inc Corporation Information

6.6.2 Pfizer Inc Description and Business Overview

6.6.3 Pfizer Inc NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Pfizer Inc NSAIDs for Dysmenorrhea Product Portfolio

6.7.5 Pfizer Inc Recent Developments/Updates

6.8 Teva

6.8.1 Teva Corporation Information

6.8.2 Teva Description and Business Overview

6.8.3 Teva NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Teva NSAIDs for Dysmenorrhea Product Portfolio

6.8.5 Teva Recent Developments/Updates

6.9 Mylan

6.9.1 Mylan Corporation Information

6.9.2 Mylan Description and Business Overview

6.9.3 Mylan NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Mylan NSAIDs for Dysmenorrhea Product Portfolio

6.9.5 Mylan Recent Developments/Updates

6.10 Apotex

6.10.1 Apotex Corporation Information

6.10.2 Apotex Description and Business Overview

6.10.3 Apotex NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Apotex NSAIDs for Dysmenorrhea Product Portfolio

6.10.5 Apotex Recent Developments/Updates

6.11 Lupin

6.11.1 Lupin Corporation Information

6.11.2 Lupin NSAIDs for Dysmenorrhea Description and Business Overview

6.11.3 Lupin NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Lupin NSAIDs for Dysmenorrhea Product Portfolio

6.11.5 Lupin Recent Developments/Updates

6.12 SANOFI-Aventis

6.12.1 SANOFI-Aventis Corporation Information

6.12.2 SANOFI-Aventis NSAIDs for Dysmenorrhea Description and Business Overview

6.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.12.4 SANOFI-Aventis NSAIDs for Dysmenorrhea Product Portfolio

6.12.5 SANOFI-Aventis Recent Developments/Updates

6.13 Boehringer-Ingelheim

6.13.1 Boehringer-Ingelheim Corporation Information

6.13.2 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Description and Business Overview

6.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product Portfolio

6.13.5 Boehringer-Ingelheim Recent Developments/Updates

6.14 BEC Chemicals

6.14.1 BEC Chemicals Corporation Information

6.14.2 BEC Chemicals NSAIDs for Dysmenorrhea Description and Business Overview

6.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.14.4 BEC Chemicals NSAIDs for Dysmenorrhea Product Portfolio

6.14.5 BEC Chemicals Recent Developments/Updates

6.15 Shandong Xinhua Pharmaceutical

6.15.1 Shandong Xinhua Pharmaceutical Corporation Information

6.15.2 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Description and Business Overview

6.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product Portfolio

6.15.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates

6.16 Hengrui Medicine

6.16.1 Hengrui Medicine Corporation Information

6.16.2 Hengrui Medicine NSAIDs for Dysmenorrhea Description and Business Overview

6.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.16.4 Hengrui Medicine NSAIDs for Dysmenorrhea Product Portfolio

6.16.5 Hengrui Medicine Recent Developments/Updates

6.17 Hubei Biocause Heilen Pharmaceutical

6.17.1 Hubei Biocause Heilen Pharmaceutical Corporation Information

6.17.2 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Description and Business Overview

6.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.17.4 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product Portfolio

6.17.5 Hubei Biocause Heilen Pharmaceutical Recent Developments/Updates

6.18 Zibo Xinhua-PERRIGO Pharmaceutical

6.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Corporation Information

6.18.2 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Description and Business Overview

6.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.18.4 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product Portfolio

6.18.5 Zibo Xinhua-PERRIGO Pharmaceutical Recent Developments/Updates

6.19 Zhejiang Jiuzhou

6.19.1 Zhejiang Jiuzhou Corporation Information

6.19.2 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Description and Business Overview

6.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.19.4 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product Portfolio

6.19.5 Zhejiang Jiuzhou Recent Developments/Updates

6.20 Hubei Xunda

6.20.1 Hubei Xunda Corporation Information

6.20.2 Hubei Xunda NSAIDs for Dysmenorrhea Description and Business Overview

6.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Sales, Revenue and Gross Margin (2018-2023)

6.20.4 Hubei Xunda NSAIDs for Dysmenorrhea Product Portfolio

6.20.5 Hubei Xunda Recent Developments/Updates

7.1 NSAIDs for Dysmenorrhea Industry Chain Analysis

7.2 NSAIDs for Dysmenorrhea Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 NSAIDs for Dysmenorrhea Production Mode & Process

7.4 NSAIDs for Dysmenorrhea Sales and Marketing

7.4.1 NSAIDs for Dysmenorrhea Sales Channels

7.4.2 NSAIDs for Dysmenorrhea Distributors

7.5 NSAIDs for Dysmenorrhea Customers

8.1 NSAIDs for Dysmenorrhea Industry Trends

8.2 NSAIDs for Dysmenorrhea Market Drivers

8.3 NSAIDs for Dysmenorrhea Market Challenges

8.4 NSAIDs for Dysmenorrhea Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global NSAIDs for Dysmenorrhea Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global NSAIDs for Dysmenorrhea Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global NSAIDs for Dysmenorrhea Market Competitive Situation by Manufacturers in 2022

    Table 4. Global NSAIDs for Dysmenorrhea Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global NSAIDs for Dysmenorrhea Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global NSAIDs for Dysmenorrhea Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global NSAIDs for Dysmenorrhea Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market NSAIDs for Dysmenorrhea Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of NSAIDs for Dysmenorrhea, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of NSAIDs for Dysmenorrhea, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of NSAIDs for Dysmenorrhea, Product Type & Application

    Table 12. Global Key Manufacturers of NSAIDs for Dysmenorrhea, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global NSAIDs for Dysmenorrhea by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs for Dysmenorrhea as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global NSAIDs for Dysmenorrhea Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global NSAIDs for Dysmenorrhea Sales by Region (2018-2023) & (K Units)

    Table 18. Global NSAIDs for Dysmenorrhea Sales Market Share by Region (2018-2023)

    Table 19. Global NSAIDs for Dysmenorrhea Sales by Region (2024-2029) & (K Units)

    Table 20. Global NSAIDs for Dysmenorrhea Sales Market Share by Region (2024-2029)

    Table 21. Global NSAIDs for Dysmenorrhea Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global NSAIDs for Dysmenorrhea Revenue Market Share by Region (2018-2023)

    Table 23. Global NSAIDs for Dysmenorrhea Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global NSAIDs for Dysmenorrhea Revenue Market Share by Region (2024-2029)

    Table 25. North America NSAIDs for Dysmenorrhea Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America NSAIDs for Dysmenorrhea Sales by Country (2018-2023) & (K Units)

    Table 27. North America NSAIDs for Dysmenorrhea Sales by Country (2024-2029) & (K Units)

    Table 28. North America NSAIDs for Dysmenorrhea Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America NSAIDs for Dysmenorrhea Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe NSAIDs for Dysmenorrhea Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe NSAIDs for Dysmenorrhea Sales by Country (2018-2023) & (K Units)

    Table 32. Europe NSAIDs for Dysmenorrhea Sales by Country (2024-2029) & (K Units)

    Table 33. Europe NSAIDs for Dysmenorrhea Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe NSAIDs for Dysmenorrhea Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific NSAIDs for Dysmenorrhea Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific NSAIDs for Dysmenorrhea Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific NSAIDs for Dysmenorrhea Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific NSAIDs for Dysmenorrhea Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific NSAIDs for Dysmenorrhea Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America NSAIDs for Dysmenorrhea Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America NSAIDs for Dysmenorrhea Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America NSAIDs for Dysmenorrhea Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America NSAIDs for Dysmenorrhea Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America NSAIDs for Dysmenorrhea Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global NSAIDs for Dysmenorrhea Sales (K Units) by Type (2018-2023)

    Table 51. Global NSAIDs for Dysmenorrhea Sales (K Units) by Type (2024-2029)

    Table 52. Global NSAIDs for Dysmenorrhea Sales Market Share by Type (2018-2023)

    Table 53. Global NSAIDs for Dysmenorrhea Sales Market Share by Type (2024-2029)

    Table 54. Global NSAIDs for Dysmenorrhea Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global NSAIDs for Dysmenorrhea Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global NSAIDs for Dysmenorrhea Revenue Market Share by Type (2018-2023)

    Table 57. Global NSAIDs for Dysmenorrhea Revenue Market Share by Type (2024-2029)

    Table 58. Global NSAIDs for Dysmenorrhea Price (US$/Unit) by Type (2018-2023)

    Table 59. Global NSAIDs for Dysmenorrhea Price (US$/Unit) by Type (2024-2029)

    Table 60. Global NSAIDs for Dysmenorrhea Sales (K Units) by Application (2018-2023)

    Table 61. Global NSAIDs for Dysmenorrhea Sales (K Units) by Application (2024-2029)

    Table 62. Global NSAIDs for Dysmenorrhea Sales Market Share by Application (2018-2023)

    Table 63. Global NSAIDs for Dysmenorrhea Sales Market Share by Application (2024-2029)

    Table 64. Global NSAIDs for Dysmenorrhea Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global NSAIDs for Dysmenorrhea Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global NSAIDs for Dysmenorrhea Revenue Market Share by Application (2018-2023)

    Table 67. Global NSAIDs for Dysmenorrhea Revenue Market Share by Application (2024-2029)

    Table 68. Global NSAIDs for Dysmenorrhea Price (US$/Unit) by Application (2018-2023)

    Table 69. Global NSAIDs for Dysmenorrhea Price (US$/Unit) by Application (2024-2029)

    Table 70. IOLCP Corporation Information

    Table 71. IOLCP Description and Business Overview

    Table 72. IOLCP NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. IOLCP NSAIDs for Dysmenorrhea Product

    Table 74. IOLCP Recent Developments/Updates

    Table 75. Granules Biocause Corporation Information

    Table 76. Granules Biocause Description and Business Overview

    Table 77. Granules Biocause NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Granules Biocause NSAIDs for Dysmenorrhea Product

    Table 79. Granules Biocause Recent Developments/Updates

    Table 80. Strides Shasun Corporation Information

    Table 81. Strides Shasun Description and Business Overview

    Table 82. Strides Shasun NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Strides Shasun NSAIDs for Dysmenorrhea Product

    Table 84. Strides Shasun Recent Developments/Updates

    Table 85. BASF Corporation Information

    Table 86. BASF Description and Business Overview

    Table 87. BASF NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. BASF NSAIDs for Dysmenorrhea Product

    Table 89. BASF Recent Developments/Updates

    Table 90. SI Group Corporation Information

    Table 91. SI Group Description and Business Overview

    Table 92. SI Group NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. SI Group NSAIDs for Dysmenorrhea Product

    Table 94. SI Group Recent Developments/Updates

    Table 95. Hisoar Corporation Information

    Table 96. Hisoar Description and Business Overview

    Table 97. Hisoar NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Hisoar NSAIDs for Dysmenorrhea Product

    Table 99. Hisoar Recent Developments/Updates

    Table 100. Pfizer Inc Corporation Information

    Table 101. Pfizer Inc Description and Business Overview

    Table 102. Pfizer Inc NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Pfizer Inc NSAIDs for Dysmenorrhea Product

    Table 104. Pfizer Inc Recent Developments/Updates

    Table 105. Teva Corporation Information

    Table 106. Teva Description and Business Overview

    Table 107. Teva NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Teva NSAIDs for Dysmenorrhea Product

    Table 109. Teva Recent Developments/Updates

    Table 110. Mylan Corporation Information

    Table 111. Mylan Description and Business Overview

    Table 112. Mylan NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Mylan NSAIDs for Dysmenorrhea Product

    Table 114. Mylan Recent Developments/Updates

    Table 115. Apotex Corporation Information

    Table 116. Apotex Description and Business Overview

    Table 117. Apotex NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Apotex NSAIDs for Dysmenorrhea Product

    Table 119. Apotex Recent Developments/Updates

    Table 120. Lupin Corporation Information

    Table 121. Lupin Description and Business Overview

    Table 122. Lupin NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. Lupin NSAIDs for Dysmenorrhea Product

    Table 124. Lupin Recent Developments/Updates

    Table 125. SANOFI-Aventis Corporation Information

    Table 126. SANOFI-Aventis Description and Business Overview

    Table 127. SANOFI-Aventis NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 128. SANOFI-Aventis NSAIDs for Dysmenorrhea Product

    Table 129. SANOFI-Aventis Recent Developments/Updates

    Table 130. Boehringer-Ingelheim Corporation Information

    Table 131. Boehringer-Ingelheim Description and Business Overview

    Table 132. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 133. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product

    Table 134. Boehringer-Ingelheim Recent Developments/Updates

    Table 135. BEC Chemicals Corporation Information

    Table 136. BEC Chemicals Description and Business Overview

    Table 137. BEC Chemicals NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 138. BEC Chemicals NSAIDs for Dysmenorrhea Product

    Table 139. BEC Chemicals Recent Developments/Updates

    Table 140. Shandong Xinhua Pharmaceutical Corporation Information

    Table 141. Shandong Xinhua Pharmaceutical Description and Business Overview

    Table 142. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 143. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product

    Table 144. Shandong Xinhua Pharmaceutical Recent Developments/Updates

    Table 145. Hengrui Medicine Corporation Information

    Table 146. Hengrui Medicine Description and Business Overview

    Table 147. Hengrui Medicine NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 148. Hengrui Medicine NSAIDs for Dysmenorrhea Product

    Table 149. Hengrui Medicine Recent Developments/Updates

    Table 150. Hubei Biocause Heilen Pharmaceutical Corporation Information

    Table 151. Hubei Biocause Heilen Pharmaceutical Description and Business Overview

    Table 152. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 153. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product

    Table 154. Hubei Biocause Heilen Pharmaceutical Recent Developments/Updates

    Table 155. Zibo Xinhua-PERRIGO Pharmaceutical Corporation Information

    Table 156. Zibo Xinhua-PERRIGO Pharmaceutical Description and Business Overview

    Table 157. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 158. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product

    Table 159. Zibo Xinhua-PERRIGO Pharmaceutical Recent Developments/Updates

    Table 160. Zhejiang Jiuzhou Corporation Information

    Table 161. Zhejiang Jiuzhou Description and Business Overview

    Table 162. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 163. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product

    Table 164. Zhejiang Jiuzhou Recent Developments/Updates

    Table 165. Hubei Xunda Corporation Information

    Table 166. Hubei Xunda Description and Business Overview

    Table 167. Hubei Xunda NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 168. Hubei Xunda NSAIDs for Dysmenorrhea Product

    Table 169. Hubei Xunda Recent Developments/Updates

    Table 170. Key Raw Materials Lists

    Table 171. Raw Materials Key Suppliers Lists

    Table 172. NSAIDs for Dysmenorrhea Distributors List

    Table 173. NSAIDs for Dysmenorrhea Customers List

    Table 174. NSAIDs for Dysmenorrhea Market Trends

    Table 175. NSAIDs for Dysmenorrhea Market Drivers

    Table 176. NSAIDs for Dysmenorrhea Market Challenges

    Table 177. NSAIDs for Dysmenorrhea Market Restraints

    Table 178. Research Programs/Design for This Report

    Table 179. Key Data Information from Secondary Sources

    Table 180. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of NSAIDs for Dysmenorrhea

    Figure 2. Global NSAIDs for Dysmenorrhea Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global NSAIDs for Dysmenorrhea Market Share by Type in 2022 & 2029

    Figure 4. Ibuprofen Product Picture

    Figure 5. Celecoxib Product Picture

    Figure 6. Ketoprofen Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global NSAIDs for Dysmenorrhea Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global NSAIDs for Dysmenorrhea Market Share by Application in 2022 & 2029

    Figure 10. Hospital

    Figure 11. Clinic

    Figure 12. Pharmacy

    Figure 13. Other

    Figure 14. Global NSAIDs for Dysmenorrhea Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global NSAIDs for Dysmenorrhea Market Size (2018-2029) & (US$ Million)

    Figure 16. Global NSAIDs for Dysmenorrhea Sales (2018-2029) & (K Units)

    Figure 17. Global NSAIDs for Dysmenorrhea Average Price (US$/Unit) & (2018-2029)

    Figure 18. NSAIDs for Dysmenorrhea Report Years Considered

    Figure 19. NSAIDs for Dysmenorrhea Sales Share by Manufacturers in 2022

    Figure 20. Global NSAIDs for Dysmenorrhea Revenue Share by Manufacturers in 2022

    Figure 21. The Global 5 and 10 Largest NSAIDs for Dysmenorrhea Players: Market Share by Revenue in 2022

    Figure 22. NSAIDs for Dysmenorrhea Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 23. Global NSAIDs for Dysmenorrhea Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 24. North America NSAIDs for Dysmenorrhea Sales Market Share by Country (2018-2029)

    Figure 25. North America NSAIDs for Dysmenorrhea Revenue Market Share by Country (2018-2029)

    Figure 26. United States NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Canada NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. Europe NSAIDs for Dysmenorrhea Sales Market Share by Country (2018-2029)

    Figure 29. Europe NSAIDs for Dysmenorrhea Revenue Market Share by Country (2018-2029)

    Figure 30. Germany NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. France NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. U.K. NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Italy NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Russia NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Asia Pacific NSAIDs for Dysmenorrhea Sales Market Share by Region (2018-2029)

    Figure 36. Asia Pacific NSAIDs for Dysmenorrhea Revenue Market Share by Region (2018-2029)

    Figure 37. China NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Japan NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. South Korea NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. India NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Australia NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. China Taiwan NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Indonesia NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Thailand NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Malaysia NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Latin America NSAIDs for Dysmenorrhea Sales Market Share by Country (2018-2029)

    Figure 47. Latin America NSAIDs for Dysmenorrhea Revenue Market Share by Country (2018-2029)

    Figure 48. Mexico NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Brazil NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Argentina NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Country (2018-2029)

    Figure 52. Middle East & Africa NSAIDs for Dysmenorrhea Revenue Market Share by Country (2018-2029)

    Figure 53. Turkey NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Saudi Arabia NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. UAE NSAIDs for Dysmenorrhea Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. Global Sales Market Share of NSAIDs for Dysmenorrhea by Type (2018-2029)

    Figure 57. Global Revenue Market Share of NSAIDs for Dysmenorrhea by Type (2018-2029)

    Figure 58. Global NSAIDs for Dysmenorrhea Price (US$/Unit) by Type (2018-2029)

    Figure 59. Global Sales Market Share of NSAIDs for Dysmenorrhea by Application (2018-2029)

    Figure 60. Global Revenue Market Share of NSAIDs for Dysmenorrhea by Application (2018-2029)

    Figure 61. Global NSAIDs for Dysmenorrhea Price (US$/Unit) by Application (2018-2029)

    Figure 62. NSAIDs for Dysmenorrhea Value Chain

    Figure 63. NSAIDs for Dysmenorrhea Production Process

    Figure 64. Channels of Distribution (Direct Vs Distribution)

    Figure 65. Distributors Profiles

    Figure 66. Bottom-up and Top-down Approaches for This Report

    Figure 67. Data Triangulation

    Figure 68. Key Executives Interviewed